Latest Pdi Inc (PDII) Headlines PDI, Inc. to Pr
Post# of 33
Posted On: 03/13/2014 1:02:05 AM
Latest Pdi Inc (PDII) Headlines
PDI, Inc. to Present at the ROTH Capital Partners 26th Annual Growth Stock Conference
PR Newswire - Tue Mar 04, 3:05PM CST
PDI, Inc. (Nasdaq: PDII) today announced that Jeff Smith, the company's chief financial officer, is scheduled to present at the ROTH Capital Partners 26th Annual Growth Stock Conference at 4:30 pm PT on March 11, 2014 at the Ritz-Carlton Laguna Nigel in Dana Point, CA.
Q4 Loss Widens at PDI, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 1:18PM CST
PDI Inc.'s fourth quarter loss came in at 25 cents per share, wider than the Zacks Consensus Estimate loss of 11 cents and the year-ago loss of 3 cents.
PDI Reports 2013 Fourth Quarter and Full Year Financial Results
PR Newswire - Thu Feb 27, 3:05PM CST
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the fourth quarter and year ended December 31, 2013. Summary financial and operational accomplishments include:
PDI, Inc. to Hold Fourth Quarter and Full Year 2013 Financial Results Conference Call on Thursday, February 27, 2014
PR Newswire - Tue Feb 18, 3:21PM CST
PDI, Inc. (Nasdaq: PDII) today announced that it will release its fourth quarter 2013 financial results on Thursday, February 27, 2014 after the market close and host a conference call beginning at 5:00 pm Eastern time to discuss the results.
Rentrak (RENT) Jumps: Stock Soars 14.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 20, 8:25AM CST
Rentrak was a big mover last session, with shares rising over 14%.
PDI, Inc. Reinvents Sales Rep And Physician Interaction With New Digital Communications Network
PR Newswire - Tue Jan 14, 7:45AM CST
PDI, Inc. (Nasdaq: PDII), today announced the launch of PD One(TM), a proprietary technology platform aimed at expanding relationships between pharmaceutical and life science manufacturers and health care providers. The subscription-based platform enables clients to extend personal and brand interactions with physicians through a secure, professional networking platform that features direct messaging and dynamic content. PDI also announced that it has contracted with a leading pharmaceutical company to provide PD One to select sales representatives across the U.S., while its own Interpace Diagnostics subsidiary will also launch the platform with its sales force.
Nasdaq stocks posting largest percentage increases
AP - Fri Jan 03, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Wider Fiscal Q2 Loss at JTH Holding - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 10, 9:24AM CST
JTH Holding's fiscal 2014 second-quarter net loss of 66 cents per share was wider than the prior-year quarter loss of 47 cents per share and the Zacks Consensus Estimate of a loss of 57 cents.
In-Line Q3 Loss at Competitive Technologies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 8:10AM CST
Competitive Technologies reported its third-quarter 2013 net loss of 4 cents per share, in line with the Zacks Consensus Estimate. The number also remained unchanged year over year.
PDI Posts Narrower Loss, Revs Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 13, 11:35AM CST
PDI's third-quarter 2013 operating net loss per share of 14 cents was narrower than the Zacks Consensus Estimate of a loss of 23 cents but widened from 6 cents in the year-ago quarter.
PDI Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 12, 3:05PM CST
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the third quarter ended September 30, 2013. Third quarter and subsequent financial and operational accomplishments include:
PDI, Inc. to Hold Third Quarter 2013 Financial Results Conference Call on Tuesday, November 12, 2013
PR Newswire - Tue Nov 05, 3:05PM CST
PDI, Inc. (Nasdaq: PDII) today announced that it will release its third quarter 2013 financial results on Tuesday, November 12, 2013 after the market close and host a conference call beginning at 5:00 pm Eastern time to discuss the results.
PDI, Inc. Appoints Molecular Diagnostics Leader to Board of Directors
PR Newswire - Wed Oct 30, 7:30AM CDT
PDI, Inc. (Nasdaq: PDII) today announced that it has appointed molecular diagnostics industry veteran John M. Climaco, J.D., to its board of directors, bringing the board to seven members.
WNS (Holdings) Beats Q2 FY14 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 17, 9:12AM CDT
WNS (Holdings) Ltd.'s operating net earnings of 33 cents per share beats the Zacks Consensus Estimate of 28 cents per share in fiscal second quarter 2014.
PDI, Inc. and Transgenomic, Inc. Partner to Commercialize Personalized Medicine Molecular Diagnostic Test
PR Newswire - Tue Oct 15, 7:00AM CDT
PDI, Inc. (Nasdaq: PDII) and Transgenomic, Inc. (OTCBB: TBIO), today announced the signing of a U.S. collaboration agreement to commercialize CardioPredict(TM), a molecular diagnostic test developed by Transgenomic. CardioPredict(TM) is a broad-based genetic assay which identifies a patient's specific genes that influence the effectiveness and safety of many commonly used cardiovascular drugs.
PDI, Inc. Enters into Collaboration Agreement to Commercialize Molecular Diagnostic Tests
PR Newswire - Tue Aug 20, 6:30AM CDT
PDI, Inc. (Nasdaq: PDII) today announced the signing of a collaboration agreement with a privately held molecular diagnostics company (the Company) to commercialize the Company's molecular diagnostic tests. The initial test to be commercialized is fully developed. For competitive reasons, the name of the company and the specific focus area of the initial test to be commercialized are not being disclosed at this time.
PDI Reports 2013 Second Quarter Financial Results
PR Newswire - Mon Aug 05, 3:01PM CDT
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the second quarter ended June 30, 2013. Summary financial and operating highlights include:
PDI, Inc. to Hold Second Quarter 2013 Financial Results Conference Call on Monday, August 5, 2013
PR Newswire - Fri Jul 26, 12:18PM CDT
PDI, Inc. (Nasdaq: PDII) today announced that it will release its second quarter 2013 financial results on Monday, August 5, 2013 after the market close and host a conference call beginning at 4:30 pm Eastern time to discuss the results.
Avis Budget Saves on Interest Expense - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 04, 10:50PM CDT
Avis Budget Group Inc. has increased its term loan facility to $1 billion, from the existing $900 million, for a lower rate of interest.
Nasdaq stocks posting largest volume increases
AP - Tue May 14, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
PDI, Inc. to Present at the ROTH Capital Partners 26th Annual Growth Stock Conference
PR Newswire - Tue Mar 04, 3:05PM CST
PDI, Inc. (Nasdaq: PDII) today announced that Jeff Smith, the company's chief financial officer, is scheduled to present at the ROTH Capital Partners 26th Annual Growth Stock Conference at 4:30 pm PT on March 11, 2014 at the Ritz-Carlton Laguna Nigel in Dana Point, CA.
Q4 Loss Widens at PDI, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 1:18PM CST
PDI Inc.'s fourth quarter loss came in at 25 cents per share, wider than the Zacks Consensus Estimate loss of 11 cents and the year-ago loss of 3 cents.
PDI Reports 2013 Fourth Quarter and Full Year Financial Results
PR Newswire - Thu Feb 27, 3:05PM CST
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the fourth quarter and year ended December 31, 2013. Summary financial and operational accomplishments include:
PDI, Inc. to Hold Fourth Quarter and Full Year 2013 Financial Results Conference Call on Thursday, February 27, 2014
PR Newswire - Tue Feb 18, 3:21PM CST
PDI, Inc. (Nasdaq: PDII) today announced that it will release its fourth quarter 2013 financial results on Thursday, February 27, 2014 after the market close and host a conference call beginning at 5:00 pm Eastern time to discuss the results.
Rentrak (RENT) Jumps: Stock Soars 14.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 20, 8:25AM CST
Rentrak was a big mover last session, with shares rising over 14%.
PDI, Inc. Reinvents Sales Rep And Physician Interaction With New Digital Communications Network
PR Newswire - Tue Jan 14, 7:45AM CST
PDI, Inc. (Nasdaq: PDII), today announced the launch of PD One(TM), a proprietary technology platform aimed at expanding relationships between pharmaceutical and life science manufacturers and health care providers. The subscription-based platform enables clients to extend personal and brand interactions with physicians through a secure, professional networking platform that features direct messaging and dynamic content. PDI also announced that it has contracted with a leading pharmaceutical company to provide PD One to select sales representatives across the U.S., while its own Interpace Diagnostics subsidiary will also launch the platform with its sales force.
Nasdaq stocks posting largest percentage increases
AP - Fri Jan 03, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Wider Fiscal Q2 Loss at JTH Holding - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 10, 9:24AM CST
JTH Holding's fiscal 2014 second-quarter net loss of 66 cents per share was wider than the prior-year quarter loss of 47 cents per share and the Zacks Consensus Estimate of a loss of 57 cents.
In-Line Q3 Loss at Competitive Technologies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 8:10AM CST
Competitive Technologies reported its third-quarter 2013 net loss of 4 cents per share, in line with the Zacks Consensus Estimate. The number also remained unchanged year over year.
PDI Posts Narrower Loss, Revs Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 13, 11:35AM CST
PDI's third-quarter 2013 operating net loss per share of 14 cents was narrower than the Zacks Consensus Estimate of a loss of 23 cents but widened from 6 cents in the year-ago quarter.
PDI Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 12, 3:05PM CST
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the third quarter ended September 30, 2013. Third quarter and subsequent financial and operational accomplishments include:
PDI, Inc. to Hold Third Quarter 2013 Financial Results Conference Call on Tuesday, November 12, 2013
PR Newswire - Tue Nov 05, 3:05PM CST
PDI, Inc. (Nasdaq: PDII) today announced that it will release its third quarter 2013 financial results on Tuesday, November 12, 2013 after the market close and host a conference call beginning at 5:00 pm Eastern time to discuss the results.
PDI, Inc. Appoints Molecular Diagnostics Leader to Board of Directors
PR Newswire - Wed Oct 30, 7:30AM CDT
PDI, Inc. (Nasdaq: PDII) today announced that it has appointed molecular diagnostics industry veteran John M. Climaco, J.D., to its board of directors, bringing the board to seven members.
WNS (Holdings) Beats Q2 FY14 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 17, 9:12AM CDT
WNS (Holdings) Ltd.'s operating net earnings of 33 cents per share beats the Zacks Consensus Estimate of 28 cents per share in fiscal second quarter 2014.
PDI, Inc. and Transgenomic, Inc. Partner to Commercialize Personalized Medicine Molecular Diagnostic Test
PR Newswire - Tue Oct 15, 7:00AM CDT
PDI, Inc. (Nasdaq: PDII) and Transgenomic, Inc. (OTCBB: TBIO), today announced the signing of a U.S. collaboration agreement to commercialize CardioPredict(TM), a molecular diagnostic test developed by Transgenomic. CardioPredict(TM) is a broad-based genetic assay which identifies a patient's specific genes that influence the effectiveness and safety of many commonly used cardiovascular drugs.
PDI, Inc. Enters into Collaboration Agreement to Commercialize Molecular Diagnostic Tests
PR Newswire - Tue Aug 20, 6:30AM CDT
PDI, Inc. (Nasdaq: PDII) today announced the signing of a collaboration agreement with a privately held molecular diagnostics company (the Company) to commercialize the Company's molecular diagnostic tests. The initial test to be commercialized is fully developed. For competitive reasons, the name of the company and the specific focus area of the initial test to be commercialized are not being disclosed at this time.
PDI Reports 2013 Second Quarter Financial Results
PR Newswire - Mon Aug 05, 3:01PM CDT
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the second quarter ended June 30, 2013. Summary financial and operating highlights include:
PDI, Inc. to Hold Second Quarter 2013 Financial Results Conference Call on Monday, August 5, 2013
PR Newswire - Fri Jul 26, 12:18PM CDT
PDI, Inc. (Nasdaq: PDII) today announced that it will release its second quarter 2013 financial results on Monday, August 5, 2013 after the market close and host a conference call beginning at 4:30 pm Eastern time to discuss the results.
Avis Budget Saves on Interest Expense - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 04, 10:50PM CDT
Avis Budget Group Inc. has increased its term loan facility to $1 billion, from the existing $900 million, for a lower rate of interest.
Nasdaq stocks posting largest volume increases
AP - Tue May 14, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
(0)
(0)Interpace Diagnostics Group, Inc. (IDXG) Stock Research Links
Scroll down for more posts ▼